named programs · 3 · from sources
What they call their work
Industry Standards Initiative
Effort to establish common scientific and ethical standards across the longevity biotechnology sector to accelerate research and development.
Member Collaboration Network
A platform for scientists, biotech founders, and researchers to collaborate on translating geroscience into therapies that target aging and age-related diseases.
Stakeholder Education Program
Initiative to educate investors, policymakers, and the public about the science of aging and the potential of longevity therapeutics.
activities · 1 group
What they do
-
Advancing Geroscience Research and Translation 3 activities
- Advocacy for gerotherapeutics developmentRepresents global leaders in geroscience and gerotherapeutics to advocate for the development of medicines that prevent and cure multiple age-related diseases. Engages stakeholders across industry, policy, and medicine to advance the field.
- Building capacity in the longevity biotechnology fieldOperates a global network connecting longevity biotech companies, pharmaceutical firms, researchers, and investors to accelerate progress in geroscience. Facilitates collaboration by creating and sharing best practices to translate research into clinical applications.
- Translating geroscience into health-span-extending interventionsConducts and supports research to translate geroscience discoveries into practical interventions that prevent age-related diseases and extend human health span. Develops standards to distinguish scientifically valid geroscience research from non-evidence-based claims in the longevity field.
-
financials · form 990EZ · fy2024
revenue
Total revenue$66K
Contributions & grants$66K100%
Program service revenue——
Investment income——
Other revenue—
expenses
Total expenses$96K
Program expenses—
Admin / overhead—
Fundraising—
Salaries & benefits$60K
Grants paid out—
balance sheet
Total assets$97K
Cash—
Investments—
Liabilities—
Net assets$97K
2 years on record · 2023–2024 · YoY revenue -45.8%
leadership · form 990 part vii · fy2024
Who runs it
paid leadership · 1
| Name | Title | Hours/wk | Compensation |
|---|---|---|---|
| Risa Starr | Executive Dir. | 40 | $60K |
relationships · 34
Who they work with
- Aevum Labs Partner — Collaborating partner in the longevity industry
- Amaro Therapeutics Partner — Collaborating partner in the longevity industry
- American Federation for Aging Research Partner — Collaborating partner in the longevity industry
- Apollo Health Ventures Partner — Collaborating partner in the longevity industry
- Aptah Bio Partner — Collaborating partner in the longevity industry
- Beyond Aging Partner — Collaborating partner in the longevity industry
- BioAge Partner — Collaborating partner in the longevity industry
- Biomarkers of Aging Partner — Collaborating partner in the longevity industry
- Buck Institute Partner — Collaborating partner in the longevity industry
- Cambrian Biopharma Partner — Collaborating partner in the longevity industry
- Eos SENOLYTIX Partner — Collaborating partner in the longevity industry
- Genflow Biosciences Partner — Collaborating partner in the longevity industry
- Gero Partner — Collaborating partner in the longevity industry
- Insilico Medicine Partner — Collaborating partner in the longevity industry
- Juvenescence Partner — Collaborating partner in the longevity industry
- Kizoo Partner — Collaborating partner in the longevity industry
- Lev Foundation Partner — Collaborating partner in the longevity industry
- Life Biosciences Partner — Collaborating partner in the longevity industry
- LongeVC Partner — Collaborating partner in the longevity industry
- Longevity Vision Fund Partner — Collaborating partner in the longevity industry
- LyGenesis Partner — Collaborating partner in the longevity industry
- Matter Bioworks Partner — Collaborating partner in the longevity industry
- NOVOS Partner — Collaborating partner in the longevity industry
- NUHS Centre for Healthy Longevity Partner — Collaborating partner in the longevity industry
- Neurodon Partner — Collaborating partner in the longevity industry
- Oviva Therapeutics Partner — Collaborating partner in the longevity industry
- Recall Therapeutics Partner — Collaborating partner in the longevity industry
- Retro Biosciences Partner — Collaborating partner in the longevity industry
- The Longevity Fund Partner — Collaborating partner in the longevity industry
- Vascarta Partner — Collaborating partner in the longevity industry
+ 4 more
strategies · 3
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Collaborative Geroscience Translationmethodology: collaborative_gersoscience_translationBy setting industry standards, educating stakeholders, and fostering collaboration, the organization advances geroscience to prevent age-related diseases and extend healthspan, because coordinated field-wide efforts accelerate scientific validation and therapeutic deployment.
- Healthspan-First Therapeutic Developmentmethodology: healthspan_extensionBy prioritizing therapies that extend healthspan rather than merely lifespan, the organization aims to produce longer periods of full, healthy living, because improving functional longevity has greater individual and societal impact than survival alone.
- Regulatory Pathway Accelerationmethodology: regulatory_accelerationBy collaborating with partners to streamline regulatory approval pathways for gerotherapeutics, the organization accelerates patient access to longevity treatments, because reducing regulatory friction decreases time-to-market and increases innovation incentives.